Drug Profile


Alternative Names: NRL972

Latest Information Update: 27 Aug 2015

Price : $50

At a glance

  • Originator Norgine
  • Class Bile acids and salts; Diagnostic agents
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Liver cirrhosis; Non-alcoholic steatohepatitis

Most Recent Events

  • 21 Oct 2005 Phase-II clinical trials in Liver disorders in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top